Table 1.

Demographics and disease characteristics. Quantitative data are presented as mean (SD) or median (IQR).

Characteristicn = 80
Age, yrs38.1 (9.1)
Male sex, n (%)40 (50.0)
Disease duration, yrs
  Symptoms9.4 (4.6–15.5)
  Diagnosis1.6 (0.3–9.1)
Smoking status, n (%)
  Current smoker32 (40.5)
  Ex-smoker17 (21.5)
  Non-smoker30 (38.0)
Current medication, n (%)
  Methotrexate4 (5.0)
  Sulfasalazine10 (12.5)
  Corticosteroids3 (3.8)
  NSAID70 (87.5)
Comorbidities, n (%)
  17 (8.8)
  24 (5.0)
  31 (1.3)
Systemic features, n (%)
  Anterior uveitis7 (8.8)
  Psoriasis9 (11.3)
  Peripheral joint involvement12 (15.0)
  Hip involvement8 (10.0)
  Shoulder involvement6 (7.5)
  GI involvement: IBD2 (2.5)
  GI involvement: other1 (1.3)
AS-related surgery, n (%)
   Unilateral hip replacement1 (1.3)
  Unilateral total shoulder replacement1 (1.3)
  Wrist/hand/ankle/foot surgery1 (1.3)
  Spinal surgery2 (2.5)
ESR, mm/h15.5 (8–26)
CRP, mg/l8.4 (3.5–19.3)
PGA7 (5–8)
BASMI2.8 (1.4)
BASFI5.1 (2.0)
BASDAI6.0 (1.7)
ASDAS-CRP3.6 (0.8)
ASDAS-ESR3.3 (0.8)
BAS-G6.9 (1.5)
WPAI, %
   Absenteeism0 (0–57.9)*
  Impairment, presenteeism49.1 (22.9)
  Work productivity loss53.1 (25.7)
  Activity impairment70 (50–80)
Patients with sick leave, %29 (43.3)
Length of sick leave in the 7 last days, hours0 (0–30)
  • * Mean (SD) absenteeism (%): 30.2 (40.6). IQR: interquartile range; NSAID: nonsteroidal antiinflammatory drug; GI: gastrointestinal; IBD: inflammatory bowel disease; AS: ankylosing spondylitis; ESR: erythrocyte sedimentation rate; CRP: C-reactive protein; PGA: physician global assessment; BASMI: Bath Ankylosing Spondylitis Metrology Index; BASFI: Bath Ankylosing Spondylitis Functional Index; BASDAI: Bath Ankylosing Spondylitis Disease Activity Index; ASDAS: Ankylosing Spondylitis Disease Activity Score; BAS-G: Bath Ankylosing Spondylitis Global Score; WPAI: Work Productivity Activity Index.